nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—ABCB1—Topotecan—cervical cancer	0.47	0.625	CbGbCtD
Clarithromycin—CYP3A4—Topotecan—cervical cancer	0.281	0.375	CbGbCtD
Clarithromycin—Heartburn—Topotecan—cervical cancer	0.0114	0.0457	CcSEcCtD
Clarithromycin—Dysmenorrhoea—Topotecan—cervical cancer	0.00861	0.0346	CcSEcCtD
Clarithromycin—Blood bilirubin increased—Topotecan—cervical cancer	0.00827	0.0332	CcSEcCtD
Clarithromycin—Pulmonary embolism—Topotecan—cervical cancer	0.00783	0.0315	CcSEcCtD
Clarithromycin—Rash maculo-papular—Topotecan—cervical cancer	0.00711	0.0286	CcSEcCtD
Clarithromycin—Neoplasm—Topotecan—cervical cancer	0.00708	0.0284	CcSEcCtD
Clarithromycin—Dermatitis bullous—Topotecan—cervical cancer	0.00594	0.0239	CcSEcCtD
Clarithromycin—Anaphylactoid reaction—Topotecan—cervical cancer	0.00587	0.0236	CcSEcCtD
Clarithromycin—Cardiac arrest—Topotecan—cervical cancer	0.0054	0.0217	CcSEcCtD
Clarithromycin—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.00512	0.0206	CcSEcCtD
Clarithromycin—Alanine aminotransferase increased—Topotecan—cervical cancer	0.00501	0.0201	CcSEcCtD
Clarithromycin—Neutropenia—Topotecan—cervical cancer	0.00459	0.0184	CcSEcCtD
Clarithromycin—Pneumonia—Topotecan—cervical cancer	0.0044	0.0177	CcSEcCtD
Clarithromycin—Infestation—Topotecan—cervical cancer	0.00438	0.0176	CcSEcCtD
Clarithromycin—Infestation NOS—Topotecan—cervical cancer	0.00438	0.0176	CcSEcCtD
Clarithromycin—Stomatitis—Topotecan—cervical cancer	0.00427	0.0171	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Topotecan—cervical cancer	0.00414	0.0166	CcSEcCtD
Clarithromycin—Epistaxis—Topotecan—cervical cancer	0.00413	0.0166	CcSEcCtD
Clarithromycin—Haemoglobin—Topotecan—cervical cancer	0.00395	0.0159	CcSEcCtD
Clarithromycin—Rhinitis—Topotecan—cervical cancer	0.00394	0.0158	CcSEcCtD
Clarithromycin—Haemorrhage—Topotecan—cervical cancer	0.00393	0.0158	CcSEcCtD
Clarithromycin—Pharyngitis—Topotecan—cervical cancer	0.0039	0.0157	CcSEcCtD
Clarithromycin—Angiopathy—Topotecan—cervical cancer	0.00357	0.0143	CcSEcCtD
Clarithromycin—Immune system disorder—Topotecan—cervical cancer	0.00355	0.0143	CcSEcCtD
Clarithromycin—Mediastinal disorder—Topotecan—cervical cancer	0.00354	0.0142	CcSEcCtD
Clarithromycin—Chills—Topotecan—cervical cancer	0.00353	0.0142	CcSEcCtD
Clarithromycin—Malnutrition—Topotecan—cervical cancer	0.00342	0.0137	CcSEcCtD
Clarithromycin—Back pain—Topotecan—cervical cancer	0.00331	0.0133	CcSEcCtD
Clarithromycin—Muscle spasms—Topotecan—cervical cancer	0.00329	0.0132	CcSEcCtD
Clarithromycin—Ill-defined disorder—Topotecan—cervical cancer	0.00317	0.0128	CcSEcCtD
Clarithromycin—Anaemia—Topotecan—cervical cancer	0.00316	0.0127	CcSEcCtD
Clarithromycin—Angioedema—Topotecan—cervical cancer	0.00313	0.0126	CcSEcCtD
Clarithromycin—Malaise—Topotecan—cervical cancer	0.00309	0.0124	CcSEcCtD
Clarithromycin—Leukopenia—Topotecan—cervical cancer	0.00306	0.0123	CcSEcCtD
Clarithromycin—Cough—Topotecan—cervical cancer	0.00299	0.012	CcSEcCtD
Clarithromycin—Chest pain—Topotecan—cervical cancer	0.00291	0.0117	CcSEcCtD
Clarithromycin—Myalgia—Topotecan—cervical cancer	0.00291	0.0117	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00289	0.0116	CcSEcCtD
Clarithromycin—Discomfort—Topotecan—cervical cancer	0.00288	0.0116	CcSEcCtD
Clarithromycin—Anaphylactic shock—Topotecan—cervical cancer	0.00279	0.0112	CcSEcCtD
Clarithromycin—Infection—Topotecan—cervical cancer	0.00277	0.0111	CcSEcCtD
Clarithromycin—Nervous system disorder—Topotecan—cervical cancer	0.00274	0.011	CcSEcCtD
Clarithromycin—Thrombocytopenia—Topotecan—cervical cancer	0.00273	0.011	CcSEcCtD
Clarithromycin—Skin disorder—Topotecan—cervical cancer	0.00271	0.0109	CcSEcCtD
Clarithromycin—Hyperhidrosis—Topotecan—cervical cancer	0.0027	0.0108	CcSEcCtD
Clarithromycin—Anorexia—Topotecan—cervical cancer	0.00266	0.0107	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00254	0.0102	CcSEcCtD
Clarithromycin—Paraesthesia—Topotecan—cervical cancer	0.00251	0.0101	CcSEcCtD
Clarithromycin—Dyspnoea—Topotecan—cervical cancer	0.00249	0.01	CcSEcCtD
Clarithromycin—Dyspepsia—Topotecan—cervical cancer	0.00246	0.00988	CcSEcCtD
Clarithromycin—Decreased appetite—Topotecan—cervical cancer	0.00243	0.00975	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Topotecan—cervical cancer	0.00241	0.00969	CcSEcCtD
Clarithromycin—Fatigue—Topotecan—cervical cancer	0.00241	0.00967	CcSEcCtD
Clarithromycin—Constipation—Topotecan—cervical cancer	0.00239	0.00959	CcSEcCtD
Clarithromycin—Pain—Topotecan—cervical cancer	0.00239	0.00959	CcSEcCtD
Clarithromycin—Feeling abnormal—Topotecan—cervical cancer	0.0023	0.00925	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Topotecan—cervical cancer	0.00228	0.00917	CcSEcCtD
Clarithromycin—Urticaria—Topotecan—cervical cancer	0.00222	0.00891	CcSEcCtD
Clarithromycin—Abdominal pain—Topotecan—cervical cancer	0.00221	0.00887	CcSEcCtD
Clarithromycin—Body temperature increased—Topotecan—cervical cancer	0.00221	0.00887	CcSEcCtD
Clarithromycin—Hypersensitivity—Topotecan—cervical cancer	0.00206	0.00827	CcSEcCtD
Clarithromycin—Asthenia—Topotecan—cervical cancer	0.002	0.00805	CcSEcCtD
Clarithromycin—Pruritus—Topotecan—cervical cancer	0.00198	0.00794	CcSEcCtD
Clarithromycin—Diarrhoea—Topotecan—cervical cancer	0.00191	0.00768	CcSEcCtD
Clarithromycin—Dizziness—Topotecan—cervical cancer	0.00185	0.00742	CcSEcCtD
Clarithromycin—Vomiting—Topotecan—cervical cancer	0.00178	0.00713	CcSEcCtD
Clarithromycin—Rash—Topotecan—cervical cancer	0.00176	0.00707	CcSEcCtD
Clarithromycin—Dermatitis—Topotecan—cervical cancer	0.00176	0.00707	CcSEcCtD
Clarithromycin—Headache—Topotecan—cervical cancer	0.00175	0.00703	CcSEcCtD
Clarithromycin—Nausea—Topotecan—cervical cancer	0.00166	0.00666	CcSEcCtD
